Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?. Yew, W. W., Chang, K. C., Chan, D. P., & Zhang, Y. Tuberculosis (Edinburgh, Scotland), 115:76–80, March, 2019. doi abstract bibtex To complement the development of new or repurposed drugs for improving the treatment outcomes of drug-susceptible and drug-resistant tuberculosis, current insight also focuses on the use of host-directed therapy. Metformin, a drug often used in the management of type 2 diabetes mellitus, has attracted attention by virtue of its favourable activity as an adjunctive agent against tuberculosis, discovered through laboratory and clinical studies. To definitively establish its role as a host-directed therapeutic in tuberculosis, more preclinical and clinical research is still required to better delineate its mechanism(s) of action and optimal clinical use.
@article{yew_metformin_2019,
title = {Metformin as a host-directed therapeutic in tuberculosis: {Is} there a promise?},
volume = {115},
issn = {1873-281X},
shorttitle = {Metformin as a host-directed therapeutic in tuberculosis},
doi = {10.1016/j.tube.2019.02.004},
abstract = {To complement the development of new or repurposed drugs for improving the treatment outcomes of drug-susceptible and drug-resistant tuberculosis, current insight also focuses on the use of host-directed therapy. Metformin, a drug often used in the management of type 2 diabetes mellitus, has attracted attention by virtue of its favourable activity as an adjunctive agent against tuberculosis, discovered through laboratory and clinical studies. To definitively establish its role as a host-directed therapeutic in tuberculosis, more preclinical and clinical research is still required to better delineate its mechanism(s) of action and optimal clinical use.},
language = {eng},
journal = {Tuberculosis (Edinburgh, Scotland)},
author = {Yew, Wing Wai and Chang, Kwok Chiu and Chan, Denise P. and Zhang, Ying},
month = mar,
year = {2019},
pmid = {30948180},
keywords = {Animals, Antitubercular Agents, Autophagy, Drug Interactions, Drug Therapy, Combination, Forecasting, Host-Pathogen Interactions, Humans, Immunity, Cellular, Latent Tuberculosis, Macrophages, Metformin, Mice, Mycobacterium tuberculosis, Oxidative Stress, Tuberculosis},
pages = {76--80},
}
Downloads: 0
{"_id":"ydMY2fL5yin8kXgyz","bibbaseid":"yew-chang-chan-zhang-metforminasahostdirectedtherapeuticintuberculosisisthereapromise-2019","author_short":["Yew, W. W.","Chang, K. C.","Chan, D. P.","Zhang, Y."],"bibdata":{"bibtype":"article","type":"article","title":"Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?","volume":"115","issn":"1873-281X","shorttitle":"Metformin as a host-directed therapeutic in tuberculosis","doi":"10.1016/j.tube.2019.02.004","abstract":"To complement the development of new or repurposed drugs for improving the treatment outcomes of drug-susceptible and drug-resistant tuberculosis, current insight also focuses on the use of host-directed therapy. Metformin, a drug often used in the management of type 2 diabetes mellitus, has attracted attention by virtue of its favourable activity as an adjunctive agent against tuberculosis, discovered through laboratory and clinical studies. To definitively establish its role as a host-directed therapeutic in tuberculosis, more preclinical and clinical research is still required to better delineate its mechanism(s) of action and optimal clinical use.","language":"eng","journal":"Tuberculosis (Edinburgh, Scotland)","author":[{"propositions":[],"lastnames":["Yew"],"firstnames":["Wing","Wai"],"suffixes":[]},{"propositions":[],"lastnames":["Chang"],"firstnames":["Kwok","Chiu"],"suffixes":[]},{"propositions":[],"lastnames":["Chan"],"firstnames":["Denise","P."],"suffixes":[]},{"propositions":[],"lastnames":["Zhang"],"firstnames":["Ying"],"suffixes":[]}],"month":"March","year":"2019","pmid":"30948180","keywords":"Animals, Antitubercular Agents, Autophagy, Drug Interactions, Drug Therapy, Combination, Forecasting, Host-Pathogen Interactions, Humans, Immunity, Cellular, Latent Tuberculosis, Macrophages, Metformin, Mice, Mycobacterium tuberculosis, Oxidative Stress, Tuberculosis","pages":"76–80","bibtex":"@article{yew_metformin_2019,\n\ttitle = {Metformin as a host-directed therapeutic in tuberculosis: {Is} there a promise?},\n\tvolume = {115},\n\tissn = {1873-281X},\n\tshorttitle = {Metformin as a host-directed therapeutic in tuberculosis},\n\tdoi = {10.1016/j.tube.2019.02.004},\n\tabstract = {To complement the development of new or repurposed drugs for improving the treatment outcomes of drug-susceptible and drug-resistant tuberculosis, current insight also focuses on the use of host-directed therapy. Metformin, a drug often used in the management of type 2 diabetes mellitus, has attracted attention by virtue of its favourable activity as an adjunctive agent against tuberculosis, discovered through laboratory and clinical studies. To definitively establish its role as a host-directed therapeutic in tuberculosis, more preclinical and clinical research is still required to better delineate its mechanism(s) of action and optimal clinical use.},\n\tlanguage = {eng},\n\tjournal = {Tuberculosis (Edinburgh, Scotland)},\n\tauthor = {Yew, Wing Wai and Chang, Kwok Chiu and Chan, Denise P. and Zhang, Ying},\n\tmonth = mar,\n\tyear = {2019},\n\tpmid = {30948180},\n\tkeywords = {Animals, Antitubercular Agents, Autophagy, Drug Interactions, Drug Therapy, Combination, Forecasting, Host-Pathogen Interactions, Humans, Immunity, Cellular, Latent Tuberculosis, Macrophages, Metformin, Mice, Mycobacterium tuberculosis, Oxidative Stress, Tuberculosis},\n\tpages = {76--80},\n}\n\n","author_short":["Yew, W. W.","Chang, K. C.","Chan, D. P.","Zhang, Y."],"key":"yew_metformin_2019","id":"yew_metformin_2019","bibbaseid":"yew-chang-chan-zhang-metforminasahostdirectedtherapeuticintuberculosisisthereapromise-2019","role":"author","urls":{},"keyword":["Animals","Antitubercular Agents","Autophagy","Drug Interactions","Drug Therapy","Combination","Forecasting","Host-Pathogen Interactions","Humans","Immunity","Cellular","Latent Tuberculosis","Macrophages","Metformin","Mice","Mycobacterium tuberculosis","Oxidative Stress","Tuberculosis"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://api.zotero.org/groups/2233678/items?key=60ayTRJxqVCJRuuZxET4IMrl&format=bibtex&limit=100","dataSources":["vYanRzz5Y4Xm7hRbC"],"keywords":["animals","antitubercular agents","autophagy","drug interactions","drug therapy","combination","forecasting","host-pathogen interactions","humans","immunity","cellular","latent tuberculosis","macrophages","metformin","mice","mycobacterium tuberculosis","oxidative stress","tuberculosis"],"search_terms":["metformin","host","directed","therapeutic","tuberculosis","promise","yew","chang","chan","zhang"],"title":"Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?","year":2019}